WITHDRAWN: Pretomanid for the treatment of Mycobacterium tuberculosis: Evidence on the development and clinical roles

Ginenus Fekadu; Kenneth K W To; Joyce H S You

doi:10.1016/j.jiph.2021.09.030

WITHDRAWN: Pretomanid for the treatment of Mycobacterium tuberculosis: Evidence on the development and clinical roles

J Infect Public Health. 2021 Oct 20:S1876-0341(21)00324-5. doi: 10.1016/j.jiph.2021.09.030. Online ahead of print.

Authors

Ginenus Fekadu¹, Kenneth K W To², Joyce H S You³

Affiliations

¹ School of Pharmacy, Faculty of Medicine, The Chinese University of Hong Kong, Shatin, N.T, Hong Kong. Electronic address: take828pharm@gmail.com.
² School of Pharmacy, Faculty of Medicine, The Chinese University of Hong Kong, Shatin, N.T, Hong Kong. Electronic address: kennethto@cuhk.edu.hk.
³ School of Pharmacy, Faculty of Medicine, The Chinese University of Hong Kong, Shatin, N.T, Hong Kong. Electronic address: joyceyou@cuhk.edu.hk.

PMID: 34742640
DOI: 10.1016/j.jiph.2021.09.030

Abstract

This article has been withdrawn at the request of the author(s) and/or editor. The Publisher apologizes for any inconvenience this may cause. The full Elsevier Policy on Article Withdrawal can be found at https://www.elsevier.com/about/our-business/policies/article-withdrawal.

Publication types

Review